A DNA Vaccine Targeting the Fetal Liver Kinase-1 (Flk-1) can Activate the Special CD8+ T Cell and Inhibit the Metastasis of Orthotopic Lewis Lung Cancer Model
- Authors
-
-
Xin Liu
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Yan Chen
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Zhi Ping Wu
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Cong Guo Jin
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Xiao Qun Chen
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Jia Li
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Yong Chun Zhou
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Xi Cai Wang
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China
-
- Keywords:
- Lung cancer, VEGFR-2, oral vaccine, angiogenesis, metastasis, orthotopic.
- Abstract
-
Lung cancer is the leading cause of cancer related deaths and need new more effective therapies. In this study, we investigated the anti-tumor effect of recombinant orally DNA vaccine delivered by attenuated S.typhimurium strain SL3261 (aroA mutant) targeting vascular endothelial growth factor receptor (VEGFR-2), also known as fetal liver kinase-1 (Flk-1) in mouse. The cDNA of extracellular domains (ECD) of VEGFR-2 (Flk-1ECD) was amplified by RT-PCR and cloned into the pcDNA3.1 (+) vector, then transformed to the attenuated S.typhimurium strain to construct the oral DNA vaccine. Then pcDNA3.1-Flk-1ECD was successfully transfected into COS-7 cells and the recombinant protein was detected by Western blot. The effect of the oral DNA vaccine was analyzed by flow cytometry (FCM) analysis and cytotoxicity assay. For mimic the local and regional growth pattern seen in lung cancer patients, the effect of the oral DNA vaccine on tumor growth and metastasis was analyzed by orthotopic cancer cells challenge in vivo. The results demonstrated that the oral DNA vaccine can overcome peripheral immune tolerance, and generated Flk-1- specific CD8+ cytotoxic T cell response. Moreover, this oral DNA vaccine could effectively reduce tumor growth, metastasis and increase the survival. It indicated that the oral VEGFR2 DNA vaccine encoding Flk-1ECD delivered by salmonella might act a potential strategy for immunotherapy of lung cancers.
- References
-
Jemal A, Siegel R, Ward E.CA Cancer J Clin 2009; 59: 225-49. http://dx.doi.org/10.3322/caac.20006
Carney DN.N Engl J Med 2002; 346: 126-8. PMID:11071679.
Herbst RS, Fidler IJ. Clin Cancer Res 2000; 6: 4604-6. PMID:11156208.
Cox G, Jones JL, Walker RA.Lung Cancer 2000; 27 : 81-100. PMID:10688491. http://dx.doi.org/10.1016/S0169-5002(99)00096-3
Marrogi AJ, Travis WD, Welsh JA.Clin Cancer Res2000; 6: 4739-44. PMID:11156228.
Fontanini G, Boldrini L, Chinè S. Br J Cancer 1999; 79: 363-9. http://dx.doi.org/10.1038/sj.bjc.6690058
Giatromanolaki A, Koukourakis MI, Kakolyris S. Clin Cancer Res 1998; 4: 3017-24. PMID:9865915.
Cross MJ, Claesson-Welsh L.Trends Pharmacol Sci 2001; 22: 201-207. PMID:11282421. http://dx.doi.org/10.1016/S0165-6147(00)01676-X
Lee SH, Mizutani N, Mizutani M.Endoglin.Cancer Immunol Immunother 2006; 55: 1565-74. http://dx.doi.org/10.1007/s00262-006-0155-5
Felicetti P, Mennecozzi M, Barucca A. Cytotherapy 2007; 9: 23-34. http://dx.doi.org/10.1080/14653240601048369
Jiao JG, Li YN, Wang H. Dig Liver Dis 2006; 38: 578-87. http://dx.doi.org/10.1016/j.dld.2006.04.014
Holmgren L, Ambrosino E, Birot O. Proc Natl Acad Sci USA 2006; 103: 9208- 9213. http://dx.doi.org/10.1073/pnas.0603110103
Bauer H, Darji A, Chakraborty T. Gene Ther 2005; 12: 364-72. http://dx.doi.org/10.1038/sj.gt.3302423
Weiss S,Chakraborty T. Curr Opin Biotechnol 2001; 12: 467-72. PMID:11604322. http://dx.doi.org/10.1016/S0958-1669(00)00247-0
Vassaux G, Nitcheu J, Jezzard S. J Pathol 2006; 208: 290-8. http://dx.doi.org/10.1002/path.1865
Yazawa K, Fujimori M, Nakamura T. Breast Cancer Res Treat 2001; 66: 165-170. http://dx.doi.org/10.1023/A:1010644217648
Agorio C, Schreiber F, Sheppard M. J Gene Med 2007; 9: 416-23. http://dx.doi.org/10.1002/jgm.1023
Ruan Z, Yang Z, Wang Y.J Immunother 2009; 32: 486-91. http://dx.doi.org/10.1097/CJI.0b013e3181a1d134
Luo Y, Markowitz D, Xiang R. Vaccine 2007; 25: 1409-15. http://dx.doi.org/10.1016/j.vaccine.2006.10.043
Zuo SG, Chen Y, Wu ZP. Biol Pharm Bull 2010; 33: 174-82. http://dx.doi.org/10.1248/bpb.33.174
Onn A, Isobe T, Itasaka S. Clin Cancer Res 2003; 9: 5532-9. PMID:14654533.
MacLachlan PR, Sanderson KE. J Bacteriol 1985; 161: 442-5. PMID:3881397.
Li Y, Wang MN, Li H.J Exp Med 2002,195: 1575-84. http://dx.doi.org/10.1084/jem.20020072
Paterson Y, Guirnalda PD,Wood LM.Semin Immunol 2010; 22: 183-9. http://dx.doi.org/10.1016/j.smim.2010.02.002
Moreno M, Kramer MG, Yim L.Curr Gene Ther 2010; 10: 56-76. http://dx.doi.org/10.2174/156652310790945566
Gentschev I, Fensterle J, Schmidt A. BMC Cancer 2005,9: 15. http://dx.doi.org/10.1186/1471-2407-5-15
Dong J, Yang J, Chen MQ. Cancer Biol Ther 2008; 7: 502-9. http://dx.doi.org/10.4161/cbt.7.4.5477
Vazquez-Torres A, Jones-Carson J, Baumler AJ. Nature 1999; 401(6755): 804- 808. http://dx.doi.org/10.1038/44593
Dunlap NE, Benjamin WH. Immunol Ser 1994; 60: 303-12. PMID:8251577.
Peters C, Paterson Y. Vaccine 2003; 21: 1187-1194. PMID:12559797. http://dx.doi.org/10.1016/S0264-410X(02)00554-6
Folkman J. Nat Med 1996; 2: 167-8. PMID:8574960.
Zhu Z, Hattori K, Zhang H. Leukemia 2003; 17: 604-11. http://dx.doi.org/10.1038/sj.leu.2402831
Brekken RA, Overholser JP, Stastny VA.Cancer Res 2000; 60: 5117-24. PMID:11016638
Zhou H, Luo Y, Mizutani M.Blood 2005; 106: 2026-32. http://dx.doi.org/10.1182/blood-2005-03-0969
Banchereau J,Steinman RM. Nature 1998; 392: 245-52. http://dx.doi.org/10.1038/32588
Paget S.Cancer Metastasis Rev 1989; 8: 98-101. PMID:2673568
- Downloads
- Published
- 2013-12-28
- Issue
- Vol. 2 No. 4 (2013)
- Section
- Articles
How to Cite
Similar Articles
- Atara Isaiah Ntekim, Oluyemisi Folake Folasire, Ayorinde Mobolande Folasire , Prevalence of Malnutrition among Cancer Patients in a Nigerian Institution , Journal of Analytical Oncology: Vol. 6 No. 2 (2017)
- Armel HerveNwabo Kamdje, Georges Kalgong, Paul Takam Kamga, Richard Simo Tagne, Jeremie Mbo Amvene, Charlette Nangue, Knowledge and Behavior of Women on Cervical Cancer in the Northern Region of Cameroon , Journal of Analytical Oncology: Vol. 6 No. 3 (2017)
- Novoa Vargas Arturo, Neoadyuvant Hormonotherpy for Posmenopausics Women with Locallity Advanced Breast Cancer , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Arpan Choudhury, Neelam Ahirwar, Rukmini Bezbaruah, Sukruti Dave, Breast Organ-Specific Surgical Practice: Perspectives of Indian Surgeons , Journal of Analytical Oncology: Vol. 14 (2025)
- B. Depboylu, N. Ozturk, B. Nigdelioglu, G. Discigil, The Relationships between Frailty and Quality of Life in Elderly Women with Breast Cancer , Journal of Analytical Oncology: Vol. 11 (2022)
- Thais Ligiero Braga , Filipe Leal Portilho, Ralph Santos-Oliveira , Breast Cancer Treatment Protocols: Systematic Review of the Last 35 Years , Journal of Analytical Oncology: Vol. 6 No. 2 (2017)
- Antonio Carrera Torres, Ángel Martínez-Sahuquillo Márquez, Isabel Gallardo Castillo, María José Cobos Fuentes, José Ramón Armas Padrón, Viability of Whole Tissue Microbiopsy (WTM) for the Study and Management of Oral Leukoplakia , Journal of Analytical Oncology: Vol. 5 No. 4 (2016)
- Cardile Venera , Avola Rosanna, C.E. Graziano Adriana, Madrid Alejandro, Russo Alessandra, Boldine Activates Intrinsic Apoptotic Pathway in DU-145 Androgen-Independent Prostate Cancer Cell Line , Journal of Analytical Oncology: Vol. 8 (2019)
- Cui Chunxiao, Lin Qing, Liu Xiaoqing, Zhao Jiping, Correlations between the Mammographic Features of Triple-Negative and Triple-Positive Breast Cancer , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- K.J. N'Dah, E. Troh, B. Doukouré, K.E. Koffi, M. Kouyaté, B.S. Koui, N.A. Aman, A.D. Abouna, K.D. Koffi, B. Traoré, A.B. Effi, M.I.J.M. Diomandé, Epidemiological and Pathological Aspects of Cervical Cancer in Ivory Coast , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
You may also start an advanced similarity search for this article.